Assessment of Cardiovascular Risks due to Methylphenidate in Six Months of Treatment in Children with Attention Deficit and Hyperactivity Disorder

ARI, Mehmet; CETIN, Ibrahim; Ekici, FİLİZ; KOCABAS, Abdullah; EMINOGLU, Sancar; GUNEY, Esra; OZTURK, Onder; DINC, Gulser; GOKER, Zeynep

doi:10.5455/bcp.20140702010106

Assessment of Cardiovascular Risks due to Methylphenidate in Six Months of Treatment in Children with Attention Deficit and Hyperactivity Disorder

Atıf İçin Kopyala

ARI M. E., CETIN I. I., Ekici F., KOCABAS A., EMINOGLU S., GUNEY E., ...Daha Fazla

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.24, sa.3, ss.248-252, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 24 Sayı: 3
Basım Tarihi: 2014
Doi Numarası: 10.5455/bcp.20140702010106
Dergi Adı: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.248-252
Anahtar Kelimeler: attention deficit and hyperactivity disorder, methylphenidate, cardiovascular risks, EPINEPHRINE, INCREASES, DRUGS
Akdeniz Üniversitesi Adresli: Hayır

Özet

Objectives: Cardiovascular adverse effects can be seen rarely in patients receiving methylphenidate for attention deficit and hyperactivity disorder (ADHD). In this study, we planned to investigate the effects of methylphenidate on the cardiovascular system in ADHD patients.